- Home
- GCT vs QURE Comparison
GCT vs QURE Comparison
Compare GCT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCT
- QURE
- Stock Information
- Founded
- GCT 2019
- QURE 1998
- Country
- GCT United States
- QURE Netherlands
- Employees
- GCT N/A
- QURE N/A
- Industry
- GCT Catalog/Specialty Distribution
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- GCT Consumer Discretionary
- QURE Health Care
- Exchange
- GCT Nasdaq
- QURE Nasdaq
- Market Cap
- GCT 798.3M
- QURE 725.4M
- IPO Year
- GCT 2022
- QURE 2007
- Fundamental
- Price
- GCT $31.03
- QURE $15.70
- Analyst Decision
- GCT Buy
- QURE Strong Buy
- Analyst Count
- GCT 2
- QURE 10
- Target Price
- GCT $24.00
- QURE $36.90
- AVG Volume (30 Days)
- GCT 1.2M
- QURE 1.1M
- Earning Date
- GCT 08-07-2025
- QURE 07-29-2025
- Dividend Yield
- GCT N/A
- QURE N/A
- EPS Growth
- GCT 19.25
- QURE N/A
- EPS
- GCT 3.31
- QURE N/A
- Revenue
- GCT $1,193,610,000.00
- QURE $14,337,000.00
- Revenue This Year
- GCT $1.98
- QURE N/A
- Revenue Next Year
- GCT $6.50
- QURE $278.91
- P/E Ratio
- GCT $9.32
- QURE N/A
- Revenue Growth
- GCT 21.20
- QURE N/A
- 52 Week Low
- GCT $11.17
- QURE $4.45
- 52 Week High
- GCT $34.50
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- GCT 67.84
- QURE 59.17
- Support Level
- GCT $29.79
- QURE $14.70
- Resistance Level
- GCT $34.50
- QURE $16.66
- Average True Range (ATR)
- GCT 1.75
- QURE 0.80
- MACD
- GCT 0.16
- QURE 0.17
- Stochastic Oscillator
- GCT 73.93
- QURE 74.54
About GCT GigaCloud Technology Inc
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.